We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
144 hedge funds and large institutions have $1.23B invested in Revance Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more call options, than puts
Call options by funds: $5.45M | Put options by funds: $1.09M
108% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 13
94% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 33
69% more capital invested
Capital invested by funds: $732M → $1.23B (+$502M)
11% more funds holding
Funds holding: 130 → 144 (+14)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
144
Holders Change
+14
Holders Change %
+10.77%
% of All Funds
2.95%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
27
Increased
64
Reduced
33
Closed
13
Calls
$5.45M
Puts
$1.09M
Net Calls
+$4.36M
Net Calls Change
+$3.57M
Top Buyers
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$24.9M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$21.5M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$11.5M |
| 4 |
BlackRock
New York
|
+$8.52M |
| 5 |
Jennison Associates
New York
|
+$8.37M |
